Recombinant EIF2AK2 anticorps

N° du produit ABIN7847700

Cet anticorps Lapin Monoclonal détecte spécifiquement EIF2AK2 dans WB et IP. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant EIF2AK2 anticorps (ABIN7847700)

Antigène: EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp EIF2AK2 est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Détail du produit anti-EIF2AK2 anticorps

Expression System: HEK-293 Cells

Fonction: Recombinant rabbit monoclonal antibody to PKR

Specificité: Recognizes endogenous levels of PKR protein

Purification: The antibody was purified by immunogen affinity chromatography.

Immunogène: KLH-conjugated synthetic peptide encompassing a sequence within human PKR protein. The exact sequence is proprietary.

Information d'application

Indications d'application: WB (1/500 - 1/1000), IP (1/10 - 1/50)

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in PBS, pH 7.4, containing 50 % glycerol, 0.2 % BSA and 0.01 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

Détails sur EIF2AK2

Antigène: EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))

Autre désignation: EIF2AK2

Sujet: PKR, PRKR, Interferon-induced, double-stranded RNA-activated protein kinase, Eukaryotic translation initiation factor 2-alpha kinase 2, eIF-2A protein kinase 2, Interferon-inducible RNA-dependent protein kinase, P1/eIF-2A protein kinase, Protein kinase RNA-activated, PKR, Tyrosine-protein kinase EIF2AK2, p68 kinase

ID gène: 5610

UniProt: P19525

Pathways: Réparation de l'ADN, ER-Nucleus Signaling, Hepatitis C